default author photo

Songmin Ying

Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province

SCHOLARLY PAPERS

4

DOWNLOADS

500

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

The Ongoing Epidemic of 2019 Novel Coronavirus (SARS-CoV-2): Infection and Fatality Trends in Wuhan, Hubei and Across China

Number of pages: 23 Posted: 25 Feb 2020
Zhejiang University - Department of Pharmacology, Harbin Medical University - Department of Cardiology, Zhejiang University - Department of Pharmacology, Zhejiang University - Department of Pharmacology, Zhejiang University - Department of Pharmacology, Zhejiang University - Department of Pharmacology, Zhejiang University - Department of Pharmacology, Zhejiang University - Department of Pharmacology, Zhejiang University - Department of Pharmacology, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province and Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province
Downloads 237 (321,897)

Abstract:

Loading...

COVID-19; China; infection and fatality trends

2.

Early-Stage Government Control of COVID-19 Limits Spreading and Reduces Fatality by Narrowing the Outbreak-Phase Duration: An Epidemiological Study

Number of pages: 46 Posted: 09 Apr 2020
Zhejiang University - Department of Pharmacology, Zhejiang University - Department of Pharmacology, Zhejiang University - Department of Pharmacology, Zhejiang University - Chu Kochen Honors College, Zhejiang University - Department of Pharmacology, Zhejiang University - Department of Pharmacology, Zhejiang University - Department of Pharmacology, Zhejiang University - Department of Pharmacology, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province and Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province
Downloads 126 (572,948)

Abstract:

Loading...

COVID-19, Epidemic, Early intervention

3.

Ensartinib Confers Potent in Vitro and in Vivo Antitumor Activity in Non-Small Cell Lung Cancer Harboring MET Exon 14-Skipping Mutations

Number of pages: 29 Posted: 05 Apr 2022
Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Zhejiang University - Department of Radiation Oncology, Zhejiang University - Department of Radiation Oncology, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province, Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province and Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province
Downloads 115 (617,542)

Abstract:

Loading...

Ensartinib, MET exon 14 skipping. mutation, non-small cell lung cancer, antitumor efficacy.

4.

Pairwise Associations Between Asthma and its Type 2 Inflammatory Comorbidities: A Systematic Review and Meta-analysis

Number of pages: 33 Posted: 27 May 2026
Zhejiang University, Zhejiang University, Zhejiang University, Zhejiang University, Zhejiang University, Zhejiang University, Zhejiang University, Zhejiang University - Department of Public Health, Zhejiang University - Department of Pharmacology and Zhejiang University - Key Laboratory of Respiratory Disease of Zhejiang Province
Downloads 22 (1,459,862)

Abstract:

Loading...

Asthma, Allergic rhinitis, Atopic dermatitis, Food allergy, Allergic conjunctivitis, Type 2 Inflammation, Allergic multimorbidity, Atopic march, Systematic review, Meta-analysis